Skip to content

Migraine Manager (R01)

Migraine Manager: An Individualized Self-Management Tool for Adolescents With Migraine (R01)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04567355
Enrollment
160
Registered
2020-09-28
Start date
2021-06-10
Completion date
2026-06-30
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine, Migraine Disorders

Keywords

Migraine

Brief summary

The objective of this trial is to test whether an online tailored intervention, Migraine Manager, is efficacious in improving headache outcomes compared to an attention control intervention in adolescents with migraines. We will conduct a randomized clinical trial to compare a sample of 80 youth (ages 11 to 17) with migraine receiving the online tailored adherence intervention to 80 youth in an attention control group. We will test whether adherence to healthy habit (hydration, regular meals, exercise, sleep) recommendations serves as a mechanism for improved headache outcomes. Clinically meaningful outcomes will be assessed by reliable, valid, and sensitive measures. The primary outcome (i.e., number of headache days) will be assessed via online daily diary pre- and post-intervention, with additional follow-up at 3, 6, 9, and 12 months. Secondary outcomes include health-related quality of life and migraine disability.

Interventions

BEHAVIORALMigraine Manager

Answers provided during the online assessment will result in certain intervention recommendations. Once assessments are completed, a treatment plan will be automatically generated for patient and parent guidance.

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The study PI, statistician, co-investigators, and all personnel who are involved in endpoint assessments will be blinded. Only one team member (lead CRC) will have access to the assignment of each participant.

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of migraine using current International Classification of Headache Disorders Criteria (ICHD-3) for migraine with or without aura * Frequency of 8 or more headaches per month * Access to the internet whether public (e.g., library) or private (e.g., home, personal) * English fluency for patient and caregiver

Exclusion criteria

* Patients with a diagnosis of pervasive developmental disorder as determined by medical chart review * Patients with a diagnosis of or serious mental illness (e.g., psychotic disorder) as determined by medical chart review

Design outcomes

Primary

MeasureTime frameDescription
Headache frequency15 monthsChange in number of days with a headache

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKevin Hommel, PhD

Children's Hospital Medical Center, Cincinnati

STUDY_CHAIRScott Powers, PhD

Children's Hospital Medical Center, Cincinnati

STUDY_CHAIRAndrew Hershey, MD, PhD

Children's Hospital Medical Center, Cincinnati

STUDY_CHAIRSusan LeCates, MSN, FNP

Children's Hospital Medical Center, Cincinnati

STUDY_CHAIRMarielle Kabbouche-Samaha, MD

Children's Hospital Medical Center, Cincinnati

STUDY_CHAIRJames Peugh, PhD

Children's Hospital Medical Center, Cincinnati

STUDY_CHAIRLee Ritterband, MD

University of Virginia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026